ALDH1A1 and neoplasm: Several cellular subcomponent changes have been described in breast cancer, including aldehyde dehydrogenase 1 (ALDH1) positivity, CD44 positivity, CD24 negativity, RHOC overexpression, hypomethylation of caveolin promoters, and deletion of some tumor suppressors [5-9].